ArticleDrug design, development and therapy2022

Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors.

Suhua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.